Dr. William Tap is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 17 years. Dr. Tap accepts several types of health insurance, listed below. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York 1275 York Avenue New York, NY 10021
R Donald Harvey, Therica M Miller, Patricia A Hurley, Ramya Thota, Lora J Black, Suanna S Bruinooge, Leigh M Boehmer, Mark E Fleury, Jasmine Kamboj, Mujahid A Rizvi, B...> ;Cancer. 2024 Apr 15
Henry de Traux de Wardin, Fabio Vanoli, Samuel C Jiang, Leonard H Wexler, Josephine K Dermawan, Samuel Singer, Ping Chi, William Tap, Cristina R Antonescu> ;JCO Precision Oncology. 2024 Apr 1
Jiangang Liu, David S Moura, Robin L Jones, Amit Aggarwal, Ebert J Philip, Jennifer Wright, Javier Martín-Broto, Andrew J Wagner, William D Tap> ;Clinical Cancer Research. 2024 Mar 27
Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia, Jean-Yves Blay, Irene Carrasco Garcia, John A Charlson, Edwin Choy, George D Dem...> ;Lancet. 2024 Apr 13
Josephine K Dermawan, Sarah Chiang, Samuel Singer, Bhumika Jadeja, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Cristina R Antonescu> ;Clinical Cancer Research. 2024 Mar 15
Ajay Subramanian, Neda Nemat-Gorgani, Timothy J Ellis-Caleo, David G P van IJzendoorn, Timothy J Sears, Anish Somani, Bogdan A Luca, Maggie Y Zhou, Martina Bradic, Ile...> ;Nature Cancer. 2024 Mar 1
Gleason, C., Dickson, M., Klein Dooley, M., Antonescu, C., Gularte-Mérida, R., Benitez, M., Delgado, J., Kataru, R., Tan, M., Bradic, M., Adamson, T., Seier, K., Richa...> ;Clinical Cancer Research. 2024 Feb 16
Denise Robinson, Hugh Leonard, Giacomo Giulio Baldi, William D Tap, Robin L Jones, Silvia Stacchiotti, Pan Pantziarka> ;Frontiers in Oncology. 2024 Jan 1
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, Brian Arnold, Max F Levine, Gunes Gundem, Juan E Arango Ossa, Dominik Glodzik, M Irene Rodríguez-Sánchez, Nan...> ;Cancer Research. 2023 Nov 15
Evan Rosenbaum, Kenneth Seier, Martina Bradic, Ciara Kelly, Sujana Movva, Benjamin A Nacev, Mrinal M Gounder, Mary L Keohan, Viswatej Avutu, Ping Chi, Katherine A Thor...> ;Cancer Research Communications. 2023 Oct 18
Wang, J., Dimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, Angelos Koulouras, Cristina R Antonescu, Murray F Brennan, Javier Martin-Broto, Piotr Rutkowsk...> ;Eclinicalmedicine. 2023 Oct 1
William D Tap, Maitreyi G Sharma, Marc Vallee, Bryan D Smith, Matthew L Sherman, Rodrigo Ruiz-Soto, Michiel van de Sande, R Lor Randall, Nicholas M Bernthal, Hans Geld...> ;Future Oncology. 2024 Mar 1
Emily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, Mark A Dickson, Evan Rosenbaum, Sandra P D'Angelo, Benjamin A Nacev, Annemarie F Shepherd, Narek Shaverdian, Suzanne...> ;Radiotherapy and Oncology. 2023 Oct 1
Josephine K Dermawan, Ciara Kelly, Zhidong Gao, Shaleigh Smith, Bhumika Jadeja, Samuel Singer, William D Tap, Ping Chi, Cristina R Antonescu> ;Clinical Cancer Research. 2023 Oct 2
Patrick Schöffski, Rastislav Bahleda, Andrew J Wagner, Melissa A Burgess, Niels Junker, Michael Chisamore, Patrick Peterson, Anna M Szpurka, Matteo Ceccarelli, William...> ;Clinical Cancer Research. 2023 Sep 1
Josephine K Dermawan, Ping Chi, William D Tap, Evan Rosenbaum, Sandra D'Angelo, Kaled M Alektiar, Cristina R Antonescu> ;The Journal of Pathology. 2023 Aug 1
Manali I Patel, Leslie Hinyard, Fay J Hlubocky, Janette K Merrill, Kimberly T Smith, Sailaja Kamaraju, Daniel Carrizosa, Tricia Kalwar, Lola Fashoyin-Aje, Scarlett L G...> ;Cancers. 2023 Jun 23
ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) + olaratumab versus dox + PBO in patients (pts) with advanced...
2019 ASCO Annual Meeting - 6/1/2019
Responder analysis of patient-reported outcomes measurement information system (PROMIS) physical function (PF) and worst stiffness among patients with tenosynovial gia...
2019 ASCO Annual Meeting - 6/1/2019
Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT).
Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical StudyApril 6th, 2023
CTOS 2022 Annual Meeting: A Phase 1/2 Study of CFT8634 Trial-in-Progress PosterNovember 18th, 2022
Memorial Sloan Kettering Cancer Center Launches New Center to Expand Commitment to Meeting the Unique Needs of Adolescents and Young Adults with CancerSeptember 21st, 2021
BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO Empire BCBS HMO Empire BCBS PPO GHI PPO
Great West PPO Health Net Oregon PPO MVP Healthcare PPO Oxford Health Freedom Oxford Health Liberty United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: